Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 106 | 42 | -1 | 0 | 6 |
| Cost of Goods | 26 | 9 | 0 | 0 | N/A |
| Gross Profit | 80 | 32 | -1 | 0 | 6 |
| Operating Expenses | 376 | 210 | 242 | 241 | 239 |
| Operating Income | -270 | -169 | -242 | -241 | -233 |
| Interest Expense | 31 | 16 | 49 | 111 | 112 |
| Other Income | 0 | 0 | -921 | 24 | 193 |
| Pre-tax Income | -301 | -184 | -1,212 | -329 | -152 |
| Net Income Continuous | -301 | -184 | -1,213 | -329 | -152 |
| Net Income Discontinuous | 238 | 238 | -5 | -27 | -156 |
| Net Income | $-63 | $54 | $-1,218 | $-356 | $-307 |
| EPS Basic Total Ops | -4.62 | 0.00 | -89.75 | -59.70 | -29.65 |
| EPS Basic Continuous Ops | -22.12 | -13.54 | -101.14 | -59.70 | -14.63 |
| EPS Basic Discontinuous Ops | 17.51 | 17.51 | -0.73 | 0.00 | -15.02 |
| EPS Diluted Total Ops | -4.62 | 0.00 | -89.75 | -59.70 | -29.65 |
| EPS Diluted Continuous Ops | -22.12 | -13.54 | -101.14 | -59.70 | -14.63 |
| EPS Diluted Discontinuous Ops | 17.51 | 17.51 | -0.73 | 0.00 | -15.02 |
| EBITDA(a) | $-242 | $-140 | $-131 | $-68 | $-60 |